154 related articles for article (PubMed ID: 35663254)
1. RS3PE Following Treatment With Combination of Hormonal Therapies Plus Ipilimumab in a Patient With Metastatic Prostate Cancer.
Kim ST; Murphy WA; Aparicio A; Subudhi SK
J Immunother Precis Oncol; 2020 Aug; 3(3):128-132. PubMed ID: 35663254
[TBL] [Abstract][Full Text] [Related]
2. Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome with Pembrolizumab for Lung Squamous Cell Carcinoma: A Case Report.
Yoshida M; Hara S; Nishioka R; Kobayashi T; Murase Y; Kimura H; Mizushima I; Kawano M
Intern Med; 2023 Dec; ():. PubMed ID: 38072406
[TBL] [Abstract][Full Text] [Related]
3. Immune Checkpoint Inhibitor-Associated Remitting Seronegative Symmetrical Synovitis With Pitting Edema: Description of a New Entity by CanRIO.
Rouhi A; Jamal S; Arreola LG; Moon D; Hudson M; Roberts J; Ladouceur A; Ye C
J Rheumatol; 2024 May; 51(5):523-528. PubMed ID: 38428960
[TBL] [Abstract][Full Text] [Related]
4. Novel Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE) Syndrome due to Insulin Therapy.
Mainali NR; Schmidt TR; Alweis R; George DL
Am J Case Rep; 2014; 15():119-22. PubMed ID: 24696753
[TBL] [Abstract][Full Text] [Related]
5. Myelodysplastic syndrome precedes the onset of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome.
Matsunaga T; Izumi Y; Iwanaga N; Kawahara C; Shigemitsu Y; Yoshida S; Kawakami A; Ogawa D; Migita K
Tohoku J Exp Med; 2015 Jan; 235(1):47-52. PubMed ID: 25744363
[TBL] [Abstract][Full Text] [Related]
6. RS3PE syndrome developing during the course of probable toxic shock syndrome: a case report.
Kyotani M; Kenzaka T; Nishio R; Akita H
BMC Infect Dis; 2018 Apr; 18(1):174. PubMed ID: 29653519
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema (RS3PE), improved following surgical resection of prostatic carcinoma: A case report.
Yajima S; Ooeda T; Inoue M; Suzuki H; Matsumoto S; Masuda H
Urol Case Rep; 2020 Sep; 32():101232. PubMed ID: 32420039
[TBL] [Abstract][Full Text] [Related]
8. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE): a form of paraneoplastic polyarthritis?
Sibilia J; Friess S; Schaeverbeke T; Maloisel F; Bertin P; Goichot B; Kuntz JL
J Rheumatol; 1999 Jan; 26(1):115-20. PubMed ID: 9918251
[TBL] [Abstract][Full Text] [Related]
9. Case Report: Resolution of remitting seronegative symmetrical synovitis with pitting edema during nivolumab therapy for gastric cancer.
Ohmura H; Kondo M; Uenomachi M; Ariyama H; Ito M; Tsuchihashi K; Ayano M; Niiro H; Akashi K; Baba E
Front Oncol; 2023; 13():1260818. PubMed ID: 37869081
[TBL] [Abstract][Full Text] [Related]
10. The clinical spectrum of remitting seronegative symmetrical synovitis with pitting edema. The Catalán Group for the Study of RS3PE.
Olivé A; del Blanco J; Pons M; Vaquero M; Tena X
J Rheumatol; 1997 Feb; 24(2):333-6. PubMed ID: 9034993
[TBL] [Abstract][Full Text] [Related]
11. Acute Onset of Remitting Seronegative Symmetrical Synovitis With Pitting Edema (RS3PE) Two Weeks After COVID-19 Vaccination With mRNA-1273 With Possible Activation of Parvovirus B19: A Case Report With Literature Review.
Arino H; Muramae N; Okano M; Mori K; Otsui K; Sakaguchi K
Cureus; 2022 May; 14(5):e24952. PubMed ID: 35706724
[TBL] [Abstract][Full Text] [Related]
12. Remitting seronegative symmetrical synovitis with pitting edema syndrome: followup for neoplasia.
Russell EB
J Rheumatol; 2005 Sep; 32(9):1760-1. PubMed ID: 16142875
[TBL] [Abstract][Full Text] [Related]
13. Remitting seronegative symmetrical synovitis with pitting edema: a case report.
Tanaka Y; Kohchi K; Kitamoto K
J Med Case Rep; 2022 Mar; 16(1):125. PubMed ID: 35331322
[TBL] [Abstract][Full Text] [Related]
14. [Two cases of RA-like and SLE-like features similar to remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome)].
Yamanishi Y; Taooka Y; Mukuzono H; Aoi K; Ishibe Y; Yamana S
Ryumachi; 1993 Apr; 33(2):162-8. PubMed ID: 8316907
[TBL] [Abstract][Full Text] [Related]
15. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study.
Cantini F; Salvarani C; Olivieri I; Barozzi L; Macchioni L; Niccoli L; Padula A; Pavlica P; Boiardi L
Ann Rheum Dis; 1999 Apr; 58(4):230-6. PubMed ID: 10364902
[TBL] [Abstract][Full Text] [Related]
16. Association of Remitting Seronegative Symmetrical Synovitis with Pitting Edema, Polymyalgia Rheumatica, and Adenocarcinoma of the Prostate.
Emamifar A; Hess S; Gildberg-Mortensen R; Jensen Hansen IM
Am J Case Rep; 2016 Feb; 17():60-4. PubMed ID: 26839040
[TBL] [Abstract][Full Text] [Related]
17. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab.
Gauci ML; Baroudjian B; Laly P; Madelaine I; Da Meda L; Vercellino L; Bagot M; Lioté F; Pages C; Lebbé C
Semin Arthritis Rheum; 2017 Oct; 47(2):281-287. PubMed ID: 28438383
[TBL] [Abstract][Full Text] [Related]
18. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome: ultrasonography as a diagnostic tool.
Agarwal V; Dabra AK; Kaur R; Sachdev A; Singh R
Clin Rheumatol; 2005 Sep; 24(5):476-9. PubMed ID: 15856369
[TBL] [Abstract][Full Text] [Related]
19. [Seronegative symmetrical synovitis with edema in both hands in patient with central cord injury].
Carbonero Martínez E; Abalos Medina GM; Ruíz Villaverde G
Rehabilitacion (Madr); 2019; 53(2):136-140. PubMed ID: 31186097
[TBL] [Abstract][Full Text] [Related]
20. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome).
Hung SC; Kung YY; Lin HY
J Formos Med Assoc; 1999 Jul; 98(7):516-8. PubMed ID: 10463003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
